Tonix Pharmaceuticals (TNXP) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts TNXP Hot Sheet
Join SI Premium – FREE
Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q4 EPS of ($0.83), $0.02 worse than the analyst estimate of ($0.81).
For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Qualcomm investor day to detail data center plans Wednesday
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
